Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Nasdaq Delists GrayMark Healthcare, A123 Systems, KIT Digital, Bidz.com And THQ

RELATED NEWS
Trade NDAQ now with 

The Nasdaq Stock Market (NDAQ: Quote) announced that it will delist the common stock of GrayMark Healthcare, Inc. GrayMark Healthcare, Inc.'s stock was suspended on November 06, 2012 and has not traded on NASDAQ since that time.

Nasdaq also announced that it will delist the common stock of A123 Systems, Inc. A123 Systems, Inc.'s stock was suspended on November 07, 2012 and has not traded on NASDAQ since that time.

Nasdaq also announced that it will delist the common stock of KIT digital, Inc. KIT digital, Inc.'s stock was suspended on December 21, 2012 and has not traded on NASDAQ since that time.

Nasdaq also announced that it will delist the common stock of Bidz.com, Inc. Bidz.com, Inc.'s stock was suspended on November 13, 2012 and has not traded on NASDAQ since that time.

Finally, Nasdaq announced that it will delist the common stock of THQ Inc. THQ Inc.'s stock was suspended on December 28, 2012 and has not traded on NASDAQ since that time.

Click here to receive FREE breaking news email alerts for Nasdaq OMX Group Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
A number of major retailers will be open on Thanksgiving for early Black Friday shopping events. Kohl's department stores will kick off Black Friday sales two hours earlier this year, at 6 p.m. Thanksgiving Day, while Macy's, Bon-Ton and Best Buy will open at the same time. J.C. Penney and Sears... Twitter Inc. has replaced its head of product Daniel Graf just six months after luring him over from Google, according to multiple reports. Graf, previously known for his work leading Google Maps, will retain his vice president of product title and work on Twitter's geolocation features, the Wall... LinkedIn Corp., the world's largest online professional network, said Thursday after the markets closed that its third quarter loss widened slightly from last year, as higher costs and expenses more than offset a 45% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.